NCT02600143View on ClinicalTrials.gov

Identification of Predictive Parameters for Colitis in Melanoma Patients Treated With Immunotherapy.

CompletedOBSERVATIONAL
Enrollment

123

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

April 30, 2019

Study Completion Date

April 30, 2019

Conditions
MelanomaColitis
Trial Locations (1)

9713 GZ

UMCG, Groningen

All Listed Sponsors
lead

University Medical Center Groningen

OTHER

NCT02600143 - Identification of Predictive Parameters for Colitis in Melanoma Patients Treated With Immunotherapy. | Biotech Hunter | Biotech Hunter